Company / Capital Expenditures
Maze Therapeutics, Inc. Capital Expenditures History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$794.0K
FY2025
5-year range
$794.0K / $794.0K
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#122 of 194
Health Care
What the data says
At $794,000, Maze Therapeutics, Inc.'s capital expenditures ranks #122 of 194 in the Health Care sector.
Based on SEC 10-K filings.
$794,000 in FY2025.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 194 in Health CareTop 63% of 194This company $794.0K Sector average $117.5M
▼
-99.3% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $794.0K | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026